Literature DB >> 19789573

Hepatitis C: CIFN for re-treatment of PEG-IFN plus RBV nonresponders?

Christian Trepo1, Pierre Pradat.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789573     DOI: 10.1038/nrgastro.2009.145

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  4 in total

Review 1.  American Gastroenterological Association technical review on the management of hepatitis C.

Authors:  Jules L Dienstag; John G McHutchison
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

2.  Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.

Authors:  Bruce R Bacon; Mitchell L Shiffman; Flavia Mendes; Reem Ghalib; Tarek Hassanein; Giuseppe Morelli; Shobha Joshi; Kenneth Rothstein; Paul Kwo; Norman Gitlin
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

3.  Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.

Authors:  Christophe Hézode; Nicole Forestier; Geoffrey Dusheiko; Peter Ferenci; Stanislas Pol; Tobias Goeser; Jean-Pierre Bronowicki; Marc Bourlière; Shahin Gharakhanian; Leif Bengtsson; Lindsay McNair; Shelley George; Tara Kieffer; Ann Kwong; Robert S Kauffman; John Alam; Jean-Michel Pawlotsky; Stefan Zeuzem
Journal:  N Engl J Med       Date:  2009-04-30       Impact factor: 91.245

4.  Successful application of highly purified natural interferon alpha (multiferon) in a chronic hepatitis C patient resistant to preceding treatment approaches.

Authors:  Eugen Musch; Mouhamad Malek; Harald von Eick; Angeliki Chrissafidou
Journal:  Hepatogastroenterology       Date:  2004 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.